UK-CAB 57: HIV and diabetes
Friday 22 January 2016
Programme
| 09.30-09.45 | Arrival |
| 09.45-10.15 | Welcome and introductions, UK-CAB updates |
| 10.00-10.30 | Internal training – Garry Brough and Paul Clift |
| 10.30-10.50 | Living with HIV and diabetes: the perfect storm – George Rodgers |
| 10.50-11.00 | BREAK |
| 11.00-11.45 | Type 2 diabetes in HIV infection – Alastair Duncan, Guys and St Thomas Hospital |
| 11.45-12.30 | Insulin resistance and diabetes mellitus in HIV infection – Dr Ana Milinkovic, UCL Mortimer Market Centre |
| 12.30-14.00 | LUNCH |
| 14.00-15.00 | Fanconi trial – Dr Frank Post, Kings College Hospital |
| 1500-15.30 | HIV respiratory disease study – Dr James Brown and Dr Marc Lipman, Royal Free Hospital |
| 15.30-15.40 | BREAK |
| 15.40-16.15 | Conferences feedback |
| 16.15-16.45 | Member feedback |
| 16.45-17.00 | AOB |
| 17.00 | Meeting close |
Presentations from this meeting
Insulin resistance and diabetes mellitus in HIV infection
Background reading
HIV and diabetes
A full guide on diabetes which is easy to read. It explains what diabetes is with a section on HIV and diabetes. You can go direct to sections of interest.
http://www.thebody.com/content/59338/diabetes-and-hivaids.html?ts=pf
Increased blood-sugar levels and risk of type 2 diabetes
Section from the i-Base guide.
http://i-base.info/guides/side/increased-blood-sugar-levels-and-risk-of-type-2-diabetes
RITA – HIV and diabetes
This issue of RITA offers a detailed look at diabetes in people with HIV. It is long document, recommend reading the interview on pages 18-22 and page 46.
http://centerforaids.org/pdfs/0215rita.pdf
Side effects of HIV medicines
Some HIV medicines may increase blood sugar levels, this articles highlights which drugs to look out for. Note that some of the drugs are no longer being used in the UK.
https://aidsinfo.nih.gov/education-materials/fact-sheets/22/59/hiv-and-diabetes
Complicaitions related to HIV/AIDS and Diabetes
HIV treatments may raise your risk of developing diabetes. If you have diabetes, HIV treatments may also make it harder for you to control your blood glucose levels.
http://www.diabetes.org/living-with-diabetes/complications/related-conditions/hivaids-and-diabetes.html
Focus: Why TB-Diabetes & TB-HIV collaborative activities are important? – 14min video
Huge evidence points towards strong association between tuberculosis (TB) and diabetes, and TB and HIV! So it makes so much more sense than ever before, for TB-diabetes and TB-HIV programmes to work collaboratively together. The video focuses on screening TB patients for diabetes, which often leads to an HIV diagnosis. The first half of the video is more relevant.
https://www.youtube.com/watch?v=PF9bILRWv1c
Financial support
The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year. This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering.
The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.
Companies that develop and market medicines have a responsibility to actively engage with advocacy organisations. HIV positive people and their advocates should also be able to ask manufacturers directly about the safety and efficacy of their products. We should be involved in their proposals for future research.
For a list of companies that support the UK-CAB please see the “about us” page.